Zhejiang Xinguang Pharmaceutical Co., Ltd. (SHE:300519)

Market Cap	2.19B
Revenue (ttm)	260.36M
Net Income (ttm)	52.10M
Shares Out	160.00M
EPS (ttm)	0.32
PE Ratio	42.71
Forward PE	n/a
Dividend	0.40 (2.92%)
Ex-Dividend Date	May 29, 2024

Volume	2,270,244
Average Volume	3,368,573
Open	13.66
Previous Close	13.56
Day's Range	13.56 - 13.79
52-Week Range	10.16 - 17.02
Beta	0.32
RSI	53.48
Earnings Date	Apr 22, 2025

About SHE:300519

Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of Chinese patent medicines, chemical medicines, and health food. It offers pharmaceutical products for vascular and trauma diseases, including respiratory system, digestive system, urinary system, pediatric diseases, and improving immunity. The company was incorporated in 1998 and is headquartered in Shengzhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Employees: 315
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300519

Financial Performance

In 2024, SHE:300519's revenue was 267.66 million, a decrease of -1.01% compared to the previous year's 270.40 million. Earnings were 50.39 million, a decrease of -21.70%.